In EGFR-mutated lung cancer cell models, EGFR mutation leads to downregulation of miR21 expression, which stabilizes TNF mRNA and activates the TNF, thereby activating NFkB signaling pathways. This evidence concerns the gene EGFR and lung carcinoma.